Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2020
[Salivary gland carcinoma]G Lassche, A C H van Engen-van Grunsven, J Honings, et al.Oral Oncology|January 7, 2022
Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinomaM J M Uijen, G Lassche, A C H van Engen-van Grunsven, et al.The American Journal of Surgical Pathology|September 28, 2010
HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct featuresA C H van Engen-van Grunsven, Marcory C R F van Dijk, Dirk J Ruiter, et al.Cancer Treatment Reviews|July 28, 2020
Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic reviewM J M Uijen, G Lassche, A C H van Engen-van Grunsven, et al.Pathology, Research and Practice|August 29, 2020
STAT3 as a predictive biomarker in head and neck cancer: A validation studyN J van Ruitenbeek, L L van der Woude, J H van Krieken, et al.Autophagy|April 23, 2016
Autophagy activity is associated with membranous sodium iodide symporter expression and clinical response to radioiodine therapy in non-medullary thyroid cancerTheo S Plantinga, Marika H Tesselaar, Hans Morreau, et al.Acta Neuropathologica|September 25, 2010
Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysisHeidi V N Küsters-Vandevelde, Ilse A C H van Engen-van Grunsven, Benno Küsters, et al.Pathology Oncology Research : POR|October 16, 2014
Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasmsHeidi V N Küsters-Vandevelde, Ilse A C H van Engen-van Grunsven, Sarah E Coupland, et al.Acta Neuropathologica|November 26, 2009
Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous systemHeidi V N Küsters-Vandevelde, Annelies Klaasen, Benno Küsters, et al.European Journal of Cancer (Oxford, England : 1990)|February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinomaW van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.Pageof 2